Chromosome 9 Loss and Bladder Cancer Recurrence
Author Information
Author(s): JMS Bartlett, AD Watters, SA Ballantyne, JJ Going, KM Grigor, TG Cooke
Primary Institution: Glasgow University Department of Surgery
Hypothesis
Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?
Conclusion
Loss of chromosome 9 in primary tumors is associated with a higher risk of recurrence in bladder cancer patients.
Supporting Evidence
- Loss of chromosome 9 was detected in 36% of patients with subsequent disease recurrence.
- Only 5% of non-recurrent patients showed loss of chromosome 9.
- The study demonstrated that chromosome 9 loss occurs early in tumorigenesis.
Takeaway
If a patient has bladder cancer and loses a piece of chromosome 9, they might have a higher chance of their cancer coming back.
Methodology
Fluorescence in situ hybridization (FISH) was used to analyze chromosome 9 copy number in tumor samples from patients.
Limitations
The study focused only on superficial tumors and may not apply to more advanced stages.
Participant Demographics
The study included 53 patients with transitional cell carcinoma, with a male-to-female ratio of approximately 3:1.
Statistical Information
P-Value
0.0085
Statistical Significance
p=0.0085
Want to read the original?
Access the complete publication on the publisher's website